AstraZeneca aims for 30 million doses of COVID-19 Vaccine for U.K. by September 2020

AstraZeneca has partnered up with the University of Oxford on the development and distribution of Oxford’s COVID-19 vaccine. The company reported expectation of the manufacture of 100 million doses by the end of the year, if vaccine proves to be safe and effective.


Biospace Inc.